

# Event Details

- **Event Name**: Angiex Private Investor Briefing - San Francisco
- **Event Start and End Date**: Mon, 12 Jan, 2026 at 05:30 pm – Mon, 12 Jan, 2026 at 07:30 pm
- **Event Description**: New Class of Oncology Therapeutics Entering Value-Creation PhaseAbout this EventFirst-in-Class Oncology Platform with Early Clinical ValidationDear Investors:Opus8 is hosting a small, invitation-only private investor briefing featuring Angiex, a clinical-stage oncology company advancing a first-in-class platform of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) for solid tumors.This closed-door session will provide direct access to Angiex’s leadership team and an opportunity to review the company’s lead Phase 1 clinical program, emerging clinical signals, platform differentiation, and upcoming milestones, as well as a discussion of current financing opportunities for accredited investors.Angiex is entering a critical value-creation phase, with early clinical data beginning to inform downstream strategic and capital formation decisions.Company OverviewAngiex is developing a new class of antibody-drug conjugates designed to deliver therapeutic payloads directly to the nucleus of tumor cells and tumor-associated vasculature. The company’s lead asset, AGX101, targets TM4SF1, a protein highly expressed in tumor blood vessels and tumor cells, with limited expression in normal adult tissues.AGX101 is currently in Phase 1 clinical trials in patients with advanced solid tumors and has demonstrated an exceptional safety profile alongside early signs of clinical activity, including stable disease and tumor shrinkage at higher dose levels.What Differentiates Angiex• First-in-Class Nuclear-Delivered ADC Platform — Designed to bypass traditional ADC resistance mechanisms through direct nuclear payload delivery• Validated Tumor Target (TM4SF1) — Enables dual targeting of tumor vasculature and tumor cells• Three Complementary Mechanisms of Action — Vascular deprivation, immune activation, and direct tumor cell killing• Outstanding Safety Profile — No observed adverse effects in primate studies at the highest dose tested• Early Clinical Validation — On-target pharmacodynamics and emerging tumor response in Phase 1Event DetailsDate: Monday, January 12, 2026Time: 5:30 – 7:30 PM PSTLocation: Fogo de Chão, 201 3rd Street, San FranciscoAttendance is strictly limited and curated.Important NotesThis meeting is intended for direct and active private investors only.All attendees must pre-register via this Eventbrite page and complete investor qualification criteria.All RSVPs are subject to review and approval.To request investor materials in advance, please contact:Skylar Rallison — srallison@opus8.comIf you have any questions, feel free to reach out to me directly. I hope you can join us Monday evening.Best,Tien WongCEO, Opus8, Inc.twong@opus8.comM: 703-932-9191
- **Event URL**: https://allevents.in/san-francisco/angiex-private-investor-briefing-san-francisco/100001979932577638
- **Event Categories**: workshops, meetups, nonprofit
- **Interested Audience**: 
  - total_interested_count: 0

## Ticket Details

- **Ticket URL**: https://consumer.pxf.io/c/1339408/3151484/39691?partnerpropertyid=1191892&MediaPartnerPropertyId=1191892&svlink=14105511&level=1&u=https%3A%2F%2Fwww.eventbrite.com%2Fe%2Fangiex-private-investor-briefing-san-francisco-tickets-1979932577638
- **Ticket Price Range**: min: 0, max: 0, currency: USD

## Event venue details

- **city**: San Francisco
- **state**: CA
- **country**: United States
- **location**: Fogo de Chão
- **lat**: 38.9144989
- **long**: -77.21958819999999
- **full address**: Fogo de Chão, 201 3rd Street, San Francisco, United States

## Event Organizer details

- **affiliate_id**: 10
- **organizer**: Opus8 Private Events (https://allevents.in/org/opus8-private-events/22542462)

## Event gallery

- **Alt text**: banner
  - **Image URL**: https://cdn-az.allevents.in/events6/banners/a9a7e363677a83c43a68d67b3915006313b4e714e0f170a11c07d2287da14779-rimg-w1200-h600-dcd9a572-gmir.jpg?v=1768193225
- **Alt text**: thumbnail
  - **Image URL**: https://cdn-az.allevents.in/events6/banners/7ee961fa949d80ef3d520c29104906ea1afcd0d07f50a7db9dbf56641156b886-rimg-w400-h400-dcd8b774-gmir.jpg?v=1768193225

## FAQs

- **Q**: When is the event happening?
  - **A:** Mon, 12 Jan, 2026 at 05:30 pm
- **Q**: Where is the event happening?
  - **A:** Fogo de Chão, 201 3rd Street, San Francisco, United States
- **Q**: What is the ticket price?
  - **A:** starting from 0 up to 0 USD
- **Q**: Who is organizing the event?
  - **A:** Opus8 Private Events
- **Q**: What type of event is this?
  - **A:** workshops, meetups, nonprofit
- **Q**: Where can I find ticket details about Angiex Private Investor Briefing - San Francisco ?
  - **A:** You can find ticket details about this event on AllEvents.

## Structured Data (JSON-LD)

```json
[
    {
        "@context": "https://schema.org",
        "@type": "Event",
        "name": "Angiex Private Investor Briefing - San Francisco",
        "image": "https://cdn-az.allevents.in/events6/banners/a9a7e363677a83c43a68d67b3915006313b4e714e0f170a11c07d2287da14779-rimg-w1200-h600-dcd9a572-gmir.jpg?v=1768193225",
        "startDate": "2026-01-12",
        "endDate": "2026-01-12",
        "url": "https://allevents.in/san-francisco/angiex-private-investor-briefing-san-francisco/100001979932577638",
        "location": {
            "@type": "Place",
            "name": "Fogo de Chão",
            "address": {
                "@type": "PostalAddress",
                "streetAddress": "201 3rd Street",
                "postalCode": "94103",
                "addressLocality": "San Francisco",
                "addressRegion": "CA",
                "addressCountry": "US"
            },
            "geo": {
                "@type": "GeoCoordinates",
                "latitude": "38.9144989",
                "longitude": "-77.21958819999999"
            }
        },
        "eventAttendanceMode": "https://schema.org/OfflineEventAttendanceMode",
        "description": "New Class of Oncology Therapeutics Entering Value-Creation Phase",
        "offers": [
            {
                "@type": "AggregateOffer",
                "availability": "https://schema.org/InStock",
                "priceCurrency": "USD",
                "availabilityStarts": "2026-03-29",
                "availabilityEnds": "2026-01-12",
                "validFrom": "2026-03-29",
                "lowPrice": "0.00",
                "highPrice": "0.00",
                "price": "0.00",
                "url": "https://allevents.in/san-francisco/angiex-private-investor-briefing-san-francisco/100001979932577638"
            },
            {
                "@type": "Offer",
                "availability": "https://schema.org/InStock",
                "priceCurrency": "USD",
                "availabilityStarts": "2026-03-29",
                "availabilityEnds": "",
                "validFrom": "2026-03-29",
                "url": "https://allevents.in/san-francisco/angiex-private-investor-briefing-san-francisco/100001979932577638",
                "price": 0,
                "name": "Investor Ticket"
            },
            {
                "@type": "Offer",
                "availability": "https://schema.org/InStock",
                "priceCurrency": "USD",
                "availabilityStarts": "2026-03-29",
                "availabilityEnds": "",
                "validFrom": "2026-03-29",
                "url": "https://allevents.in/san-francisco/angiex-private-investor-briefing-san-francisco/100001979932577638",
                "price": 0,
                "name": "Investment Advisor/Representative/RIA Ticket"
            }
        ],
        "organizer": [
            {
                "@type": "Organization",
                "name": "Opus8 Private Events",
                "url": "https://allevents.in/org/opus8-private-events/22542462",
                "description": "Opus8 directly invests in and helps raise capital for, exceptional entrepreneurs and fund managers."
            }
        ]
    }
]
```